Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 14, 2025 - Prasco launched an authorized brand alternative of GSK’s Anoro Ellipta (umeclidinium/vilanterol) inhalation.
Download PDF
Return to publications